News - Page 206 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Post published:February 18, 2021
Post category:Press Release

Read more about the article MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 18, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

Post published:February 18, 2021
Post category:Press Release

Read more about the article Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

Post published:February 18, 2021
Post category:Press Release

Read more about the article Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement

Post published:February 17, 2021
Post category:Press Release

Read more about the article Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Post published:February 17, 2021
Post category:Press Release

Read more about the article Revive Therapeutics Acquires Unique Psilocybin Assets

Revive Therapeutics Acquires Unique Psilocybin Assets

Post published:February 17, 2021
Post category:Press Release

Read more about the article PharmaTher Announces Sale of Psilocybin Program

PharmaTher Announces Sale of Psilocybin Program

Post published:February 17, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Completes $2 Million Strategic Financing

Tryp Therapeutics Completes $2 Million Strategic Financing

Post published:February 17, 2021
Post category:Press Release

Read more about the article Mind Cure Comments on Recent Promotional Activity

Mind Cure Comments on Recent Promotional Activity

Post published:February 17, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.